Meeting Banner
Abstract #2235

Intracellular pH measured by 31 P MR-Spectroscopy predicts site of progression in recurrent glioblastoma under antiangiogenic therapy with bevacizumab.

Katharina Johanna Wenger 1 , Oliver Bhr 1 , Elke Hattingen 2 , and Ulrich Pilatus 2

1 Neurooncology, Goethe-University Frankfurt, Frankfurt, Hessen, Germany, 2 Neuroradiology, Goethe-University Frankfurt, Frankfurt, Hessen, Germany

In solid tumors, major changes in the expression and/or activity of plasma membrane ion pumps and transporters facilitate proton efflux and enable tumor cells to maintain a higher intracellular pH (pHi), while the microenvironment (pHe) is commonly more acidic compared to normal differentiated adult cells. An alkaline pHi supports various mechanisms involved in cellular proliferation and limits apoptosis, therefore promoting cell survival. We proposed that these early changes in pH take place before an MR-detectable recurrence occurs. To prove our hypothesis, we employed in-vivo 31P MR spectroscopic imaging (MRSI) in patients with recurrent glioblastoma (rGBM) before and under antiangiogenetic therapy (bevacizumab, BEV) until tumor progression. According to the predefined criteria by Pope et al. for distant or diffuse tumor progression, 14 patients of our institution were selected based on their tumor progression patterns at time of on-study progression (subsequent tumor). An area of interest for voxel selection on baseline MRSI data was defined retrospectively at the site of the subsequent tumor. The area of interest showed no detectable lesions before BEV on standard MRI sequences. The pHi in the area of interest (subsequent tumor) was significantly higher than the pHi of the contralateral normal appearing tissue (control) (p < 0.001) and similar to the pHi of the existing tumor. Elevated pHi in radiographically normal appearing tissue at baseline can predict the site of subsequent progression in patients with recurrent glioblastoma treated with BEV.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.

Keywords